Lin Xuehua intends to acquire 45% stake in Beijing Zhongrun Weiye Investment Co., Ltd. from Beijing Science Sun Pharmaceutical Co., Ltd. (SZSE:300485) for CNY 6.65 million on January 6, 2023. The board of directors of Beijing Science Sun Pharmaceutical approved the transaction. The definitive agreement will be signed by January 13, 2023 and within 5 working days of the agreement being signed the buyer shall remit the equity transfer payment in one lump sum.

Beijing Zhongrun Weiye Investment recorded Total assets of CNY 649.71 million and net assets of CNY 4.69 million as of September 30, 2022.